Skip to main content

Advertisement

Log in

Regulation of Hepatitis C virus replication and gene expression by the MAPK-ERK pathway

Virologica Sinica

Abstract

The mitogen activated protein kinases-extracellular signal regulated kinases (MAPK-ERK) pathway is involved in regulation of multiple cellular processes including the cell cycle. In the present study using a Huh7 cell line Con1 with an HCV replicon, we have shown that the MAPK-ERK pathway plays a significant role in the modulation of HCV replication and protein expression and might influence IFN-α signalling. Epithelial growth factor (EGF) was able to stimulate ERK activation and decreased HCV RNA load while a MAPK-ERK pathway inhibitor U0126 led to an elevated HCV RNA load and higher NS5A protein amounts in Con1 cells. It could be further demonstrated that the inhibition of the MAPK-ERK pathway facilitated the translation directed by the HCV internal ribosome entry site. Consistently, a U0126 treatment enhanced activity of the HCV reporter replicon in transient transfection assays. Thus, the MAPK-ERK pathway plays an important role in the regulation of HCV gene expression and replication. In addition, cyclin-dependent kinases (CDKs) downstream of ERK may also be involved in the modulation of HCV replication since roscovitine, an inhibitor of CDKs had a similar effect to that of U0126. Modulation of the cell cycle progression by cell cycle inhibitor or RNAi resulted consistently in changes of HCV RNA levels. Further, the replication of HCV replicon in Con1 cells was inhibited by IFN-α. The inhibitory effect of IFN-α could be partly reversed by pre-incubation of Con-1 cells with inhibitors of the MAPK-ERK pathway and CDKs. It could be shown that the MAPK-ERK inhibitors are able to partially modulate the expression of interferon-stimulated genes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aktas H, Cai H, Cooper G M. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin d1 and the cdk inhibitor p27kip1. Mol Cell Biol, 17(7): 3850–3857.

    PubMed  CAS  Google Scholar 

  2. Alter M J. 1997. Epidemiology of hepatitis c. Hepatology, 26(S3): 62S–65S.

    Article  PubMed  CAS  Google Scholar 

  3. Bartenschlager R. 2006. Hepatitis c virus molecular clones: From cdna to infectious virus particles in cell culture. Current Opinion in Microbiology, 9(4): 416–422.

    Article  PubMed  CAS  Google Scholar 

  4. Binder M, Kochs G, Bartenschlager R, et al. 2007. Hepatitis c virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology, 46(5): 1365–1374.

    Article  PubMed  CAS  Google Scholar 

  5. Broering R, Wu J, Meng Z, et al. 2008. Toll-like receptorstimulated non-parenchymal liver cells can regulate hepatitis c virus replication. J Hepatol, 48(6): 914–922.

    Article  PubMed  CAS  Google Scholar 

  6. Brunet A, Danie’ Le Roux, Lenorm P, et al. 1999. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. The EMBO Journal, 18(3): 664–674.

    Article  PubMed  CAS  Google Scholar 

  7. Chang Y, Lei Y, Wu W, et al. 2007. Effect of hepatitis c virus core protein on interferon-induced antiviral genes expression and its mechanisms. Virologica Sinica, 22(5): 274–379.

    Article  Google Scholar 

  8. Choo Q L, Kuo G, Weinera J, et al. 1989. Isolation of a cdna clone derived from a blood-borne non-a, non-b viral hepatitis genome. Science, 244(4902): 359–362.

    Article  PubMed  CAS  Google Scholar 

  9. Cyert M S. 2001. Regulation of nuclear localization during signaling. J Biol Chem, 276(24): 20805–20808.

    Article  PubMed  CAS  Google Scholar 

  10. Fimia G M, Evangelisti C, Alonzi T, et al. 2004. Conventional protein kinase c inhibition prevents alpha interferon-mediated hepatitis c virus replicon clearance by impairing stat activation. J Virol, 78(23): 12809–12816.

    Article  PubMed  CAS  Google Scholar 

  11. Foy E, Li K, Wang C, et al. 2003. Regulation of interferon regulatory factor-3 by the hepatitis c virus serine protease. Science, 300(5622): 1145–1148.

    Article  PubMed  CAS  Google Scholar 

  12. Foy E, Li K, Sumpter R, Jr, et al. 2005. Control of antiviral defenses through hepatitis c virus disruption of retinoic acid-inducible gene-i signaling. Proc Natl Acad Sci U S A, 102(8): 2986–2991.

    Article  PubMed  CAS  Google Scholar 

  13. Frese M, Schwarzle V, Barth K, et al. 2002. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis c virus rnas. Hepatology, 35(3): 694–703.

    Article  PubMed  CAS  Google Scholar 

  14. Gretton S, Hughes M, Harris M. 2010. Hepatitis c virus rna replication is regulated by ras-erk signalling. J Gen Virol, 91(Pt 3): 671–680.

    Article  PubMed  CAS  Google Scholar 

  15. Guo J-T, Zhu Q, Seeger C. 2003. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis c virus subgenomic replicons. J Virol, 77(20): 10769–10779.

    Article  PubMed  CAS  Google Scholar 

  16. Huang Y, Chen X C, Konduri M, et al. 2006. Mechanistic link between the anti-hcv effect of interferon gamma and control of viral replication by a ras-mapk signaling cascade. Hepatology, 43(1): 81–90.

    Article  PubMed  CAS  Google Scholar 

  17. Kawada M, Yamagoe S, Murakami Y, et al. 1997. Induction of p27kip1 degradation and anchorage independence by ras through the map kinase signaling pathway. Oncogene, 15(6): 629–637.

    Article  PubMed  CAS  Google Scholar 

  18. Krieger N, Lohmann V, Bartenschlager R. 2001. Enhancement of hepatitis c virus rna replication by cell culture-adaptive mutations. J Virol, 75(10): 4614–4624.

    Article  PubMed  CAS  Google Scholar 

  19. Li K, Foy E, Ferreon J C, et al. 2005. Immune evasion by hepatitis c virus ns3/4a protease-mediated cleavage of the toll-like receptor 3 adaptor protein trif. Proc Natl Acad Sci U S A, 102(8): 2992–2997.

    Article  PubMed  CAS  Google Scholar 

  20. Lindenbach B D, Evans M J, Syder a J, et al. 2005. Complete replication of hepatitis c virus in cell culture. Science, 309(5734): 623–626.

    Article  PubMed  CAS  Google Scholar 

  21. Lohmann V, Ouml, Rner F, et al. 1999. Replication of subgenomic hepatitis c virus rnas in a hepatoma cell line. Science, 285(5424): 110–113.

    Article  PubMed  CAS  Google Scholar 

  22. Maccorkle R, Tan T-H. 2005. Mitogen-activated protein kinases in cell-cycle control. Cell Biochemistry and Biophysics, 43(3): 451–461.

    Article  PubMed  CAS  Google Scholar 

  23. Macdonald A, Chan J K Y, Harris M. 2005. Perturbation of epidermal growth factor receptor complex formation and ras signalling in cells harbouring the hepatitis c virus subgenomic replicon. J Gen Virol, 86(4): 1027–1033.

    Article  PubMed  CAS  Google Scholar 

  24. Macdonald A, Crowder K, Street A, et al. 2003. The hepatitis c virus non-structural ns5a protein inhibits activating protein-1 function by perturbing ras-erk pathway signaling. J Biol Chem, 278(20): 17775–17784.

    Article  PubMed  CAS  Google Scholar 

  25. Mankouri J, Griffin S, Harris M. 2008. The hepatitis c virus non-structural protein ns5a alters the trafficking profile of the epidermal growth factor receptor. Traffic, 9(9): 1497–1509.

    Article  PubMed  CAS  Google Scholar 

  26. Mannova P, Beretta L. 2005. Activation of the n-ras-pi3k-aktmtor pathway by hepatitis c virus: Control of cell survival and viral replication. J Virol, 79(14): 8742–8749.

    Article  PubMed  CAS  Google Scholar 

  27. Meloche S, Pouyssegur J. 2007. The erk1//2 mitogen-activated protein kinase pathway as a master regulator of the g1-to s-phase transition. Oncogene, 26(22): 3227–3239.

    Article  PubMed  CAS  Google Scholar 

  28. Meylan E, Curran J, Hofmann K, et al. 2005. Cardif is an adaptor protein in the rig-i antiviral pathway and is targeted by hepatitis c virus. Nature, 437(7062): 1167–1172.

    Article  PubMed  CAS  Google Scholar 

  29. Murata T, Hijikata M, Shimotohno K. 2005. Enhancement of internal ribosome entry site-mediated translation and replication of hepatitis c virus by pd98059. Virology, 340(1): 105–115.

    Article  PubMed  CAS  Google Scholar 

  30. Ndjomou J, Park I W, Liu Y, et al. 2009. Up-regulation of hepatitis c virus replication and production by inhibition of mek/erk signaling. PLoS One, 4(10): e7498.

    Article  PubMed  Google Scholar 

  31. Nelson H B, Tang H. 2006. Effect of cell growth on hepatitis c virus (hcv) replication and a mechanism of cell confluence-based inhibition of hcv rna and protein expression. J Virol, 80(3): 1181–1190.

    Article  PubMed  CAS  Google Scholar 

  32. Schaeffer H J, Weber M J. 1999. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol, 19(4): 2435–2444.

    PubMed  CAS  Google Scholar 

  33. Seeff L B. 1997. Natural history of hepatitis c. Hepatology, 26(S3): 21S–28S.

    Article  PubMed  CAS  Google Scholar 

  34. Street A, Macdonald A, Crowder K, et al. 2004. The hepatitis c virus ns5a protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem, 279(13): 12232–12241.

    Article  PubMed  CAS  Google Scholar 

  35. Sumpter R, Jr, Loo Y M, Foy E, et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis c virus rna replication through a cellular rna helicase, rig-i. J Virol, 79(5): 2689–2699.

    Article  PubMed  CAS  Google Scholar 

  36. Takuwa N, Takuwa Y. 1997. Ras activity late in g1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into s phase in growth factor-stimulated nih 3t3 fibroblasts. Mol Cell Biol, 17(9): 5348–5358.

    PubMed  CAS  Google Scholar 

  37. Tong M J, El-Farra N S, Reikes a R, et al. 1995. Clinical outcomes after transfusion-associated hepatitis c. N Engl J Med, 332(22): 1463–1466.

    Article  PubMed  CAS  Google Scholar 

  38. Trujillo-Murillo K, Rincon-Sancheza R, Martinez-Rodriguez H, et al. 2008. Acetylsalicylic acid inhibits hepatitis c virus rna and protein expression through cyclooxygenase 2 signaling pathways. Hepatology, 47(5): 1462–1472.

    Article  PubMed  CAS  Google Scholar 

  39. Wakita T, Pietschmann T, Kato T, et al. 2005. Production of infectious hepatitis c virus in tissue culture from a cloned viral genome. Nat Med, 11(7): 791–796.

    Article  PubMed  CAS  Google Scholar 

  40. Yokota T, Sakamoto N, Enomoto N, et al. 2003. Inhibition of intracellular hepatitis c virus replication by synthetic and vector-derived small interfering rnas. EMBO Rep, 4(6): 602–608.

    Article  PubMed  CAS  Google Scholar 

  41. Zhong J, Gastaminza P, Cheng G, et al. 2005. Robust hepatitis c virus infection in vitro. Proc Natl Acad Sci USA, 102(26): 9294–9299.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xinwen Chen.

Additional information

Foundation items: Partly supported by a joint grant of Chinese Academy of Science and Deutsche Akademische Austausch Dienst, and the the National Basic Research Priorities Program of China (2009CB522501, 2005CB522901, 2007CB512901).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pei, R., Zhang, X., Xu, S. et al. Regulation of Hepatitis C virus replication and gene expression by the MAPK-ERK pathway. Virol. Sin. 27, 278–285 (2012). https://doi.org/10.1007/s12250-012-3257-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12250-012-3257-6

Keywords

Navigation